Integrated Synthesis, Crystallization, Filtration, and Drying of Active Pharmaceutical Ingredients: A Model-Based Digital Design Framework for Process Optimization and Control-Reference-Cited by-同舟云学术

Integrated Synthesis, Crystallization, Filtration, and Drying of Active Pharmaceutical Ingredients: A Model-Based Digital Design Framework for Process Optimization and Control

Published:2022 Issue: Volume: Page:253-287
ISSN:1931-6828
Container-title:Optimization of Pharmaceutical Processes
language:
Short-container-title:

Author:

Laky Daniel J.,Casas-Orozco Daniel,Destro Francesco,Barolo Massimiliano,Reklaitis Gintaras V.,Nagy Zoltan K.

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-030-90924-6_10

Reference45 articles.

1. FDA (2004) ‘Pharmaceutical cgmps for the 21 st century-a risk-based approach final report’.

2. Su, Q., Ganesh, S., Moreno, M., Bommireddy, Y., Gonzalez, M., Reklaitis, G. V., et al. (2019) ‘A perspective on Quality-by-Control (QbC) in pharmaceutical continuous manufacturing’, Computers and Chemical Engineering. Elsevier Ltd, 125, pp. 216–231. doi: https://doi.org/10.1016/j.compchemeng.2019.03.001.

3. FDA (2009) ‘Guidance for Industry Q8(R2) Pharmaceutical Development’. Available at: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htm.

4. Rojko, A. (2017) ‘Industry 4.0 concept: Background and overview’, International Journal of Interactive Mobile Technologies. International Association of Online Engineering, 11(5), pp. 77–90. doi: https://doi.org/10.3991/ijim.v11i5.7072.

5. García-Muñoz, S. et al. (2015) ‘Definition of Design Spaces Using Mechanistic Models and Geometric Projections of Probability Maps’, Organic Process Research and Development, 19(8), pp. 1012–1023. doi: https://doi.org/10.1021/acs.oprd.5b00158.